PALVELLA THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PVLA)

Historical Holders from Q4 2024 to Q3 2025

Symbol
PVLA on Nasdaq
CUSIP
697947109
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
11.8M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
8.53M
Holdings value
$534M
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
98
Number of buys
66
Number of sells
-26
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PALVELLA THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PVLA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Kaupinen Wes 14.6% $39.4M 1.64M Kaupinen Wes Dec 13, 2024
BIOTECHNOLOGY VALUE FUND L P 9.99% $74M 1.18M BVF PARTNERS L P/IL Sep 30, 2025
SUVRETTA CAPITAL MANAGEMENT, LLC 7.4% -13.3% $51.6M $6.77M 822K +15.1% SUVRETTA CAPITAL MANAGEMENT, LLC Sep 30, 2025
Frazier Life Sciences Public Fund, L.P. 4.9% -23.3% $28M -$7.41M 546K -20.9% Frazier Life Sciences Public Fund, L.P. Jun 30, 2025
Samsara BioCapital, L.P. 3.1% -50% $17.4M -$17.4M 340K -50% Samsara BioCapital, L.P. Jun 30, 2025
Dellora Investments LP 1.3% $3.38M 141K Dellora Investments LP Dec 13, 2024

Institutional Holders of PALVELLA THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PVLA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 8.53M $534M +$183M $62.69 98
2025 Q2 5.91M $133M +$16.6M $22.54 64
2025 Q1 5.12M $143M +$33.7M $27.99 40
2024 Q4 4.03M $48.4M +$48.4M $12.00 32